Adipocytes undergo considerable volumetric expansion in the setting of obesity. It has been proposed that such marked increases in adipocyte size may be sensed via adipocyte-autonomous mechanisms to mediate size-dependent intracellular signalling. Here, we show that SWELL1 (LRRC8a), a member of the Leucine-Rich Repeat Containing protein family, is an essential component of a volume-sensitive ion channel (VRAC) in adipocytes. We find that SWELL1-mediated VRAC is augmented in hypertrophic murine and human adipocytes in the setting of obesity. SWELL1 regulates adipocyte insulin-PI3K-AKT2-GLUT4 signalling, glucose uptake and lipid content via SWELL1 C-terminal leucine-rich repeat domain interactions with GRB2/Cav1. Silencing GRB2 in SWELL1 KO adipocytes rescues insulin-pAKT2 signalling. In vivo, shRNA-mediated SWELL1 knockdown and adipose-targeted SWELL1 knockout reduce adiposity and adipocyte size in obese mice while impairing systemic glycaemia and insulin sensitivity. These studies identify SWELL1 as a cell-autonomous sensor of adipocyte size that regulates adipocyte growth, insulin sensitivity and glucose tolerance.
The adipocyte maximizes energy storage by forming a large lipid droplet, separated from the plasma membrane by a thin rim of cytoplasm, while maintaining a tremendous capacity for volumetric expansion-increasing >30-fold in the setting of obesity 1 . This lipid droplet growth augments adipocyte stiffness, thereby reducing membrane compliance 2 and increasing membrane tension, which in turn has been shown to activate intracellular signalling pathways 3, 4 , implying that adipocytes may be mechano-sensitive 4 . Moreover, adipocyte size in obesity has been correlated with the severity of linked diseases such as diabetes and insulin resistance 5, 6 , suggesting that increases in adipocyte volume 1 or membrane tension 7 may alter intracellular signalling. Others propose that caveolae enable expanding adipocytes to auto-regulate lipid content based on mechanical lipid droplet-plasma membrane interactions 8 and tune insulin signalling in response to adipocyte swelling 9 . However, the molecular identity of a putative adipocyte volume sensor remains a mystery.
Ion channels are membrane proteins that can signal in response to membrane stretch, and accordingly provide plausible candidates for adipocyte membrane stretch sensors that bridge membrane tension with intracellular signalling. There are a number of candidate stretch/mechano-sensitive ion channels in mammalian cells, including TRPM7 (refs 10,11), TRPV2 (ref. 12 ), TRPV4 (ref. 13 ), TRPC6 (ref. 14) and Piezo-1/Piezo-2 (ref. 15 ). Many of these ion channels are expressed in adipocytes 16 , and have signalling roles important for adipogenesis 16 , fatty acid sensing 17 , oxidative metabolism, inflammation and energy homeostasis 18 .
In this study, we explored swell-activated ion channel signalling in adipocytes by applying the patch-clamp technique to freshly isolated, mature murine and human adipocytes. Using this approach, we identified a prominent swell-activated chloride current in adipocytes, characteristic of the volume-regulated anion current (VRAC), and discovered that the gene LRRC8a, a member of the Leucine-Rich Repeat (LRR) Containing proteins 19, 20 (SWELL1), is required for adipocyte VRAC. Interestingly, Kumar et al. 21 , unaware of the volume-sensitive ion channel function of SWELL1 (LRRC8a), recently showed that it can signal via phosphoinositide 3-kinase (PI3K)/AKT in lymphocytes, a pathway known to be important for lipid and glucose homeostasis in adipocytes 22, 23 . On the background of these recent findings we hypothesized that SWELL1 may participate in sensing adipocyte volume during physiological or pathophysiological adipocyte expansion and engage insulin-PI3K-AKT signallingthereby coupling adipocyte growth with insulin signalling. Herein, we link the volume-sensitive SWELL1 molecule to adipocyte insulin signalling and growth; and propose a model in which SWELL1 activates in response to adipocyte expansion, and tunes insulinmediated activation of growth and glucose import pathways.
Adipocyte patch clamp reveals prominent swell-activated current in murine and human adipocytes
To identify a putative swell-activated ionic current in adipocytes we performed patch-clamp recordings on mature murine adipocytes freshly isolated from inguinal white adipose tissue (iWAT). We measured ionic currents in voltage-clamp mode while simultaneously swelling the adipocyte by applying positive pressure (∼3-5 mmHg, whole-cell configuration) via the patch pipette ( Fig. 1a-Swelled) . After a few minutes, we observed activation of a large swellactivated current (Fig. 1b,c) . This current is outward rectifying, characterized by larger outward current at positive voltages compared to inward currents at negative voltages during sequential voltage ramps (Fig. 1b ,c) or voltage steps ( Fig. 1d ), with the current amplitude proportional to the extent of adipocyte swelling ( Fig. 1e-g ). This current reverses at −11.7 ± 2.5 mV, which is near the reversal potential of chloride under our conditions (−11.5 mV, junction potential corrected). Application of low-chloride extracellular solution largely abolished the outward component of this current and shifted the current reversal towards 0 mV ( Fig. 1h ), suggesting a predominant chloride conductance. Finally, this swell-activated adipocyte current is blocked by 4-[(2-Butyl-6,7-dichloro-2-cyclopentyl-2,3-dihydro-1oxo-1H -inden-5-yl)oxy]butanoic acid (DCPIB), a selective blocker of the volume-regulated anion current (VRAC) or volume-sensitive outwardly rectifying chloride current (VSOR) (Fig. 1b,c) . We also confirmed this swell-activated current to be present in the murine 3T3-F442A ( Fig. 1i ) and human adipocyte cell lines ( Fig. 1j , NPAD; ref. 24 ) upon hypotonic swelling, and this current is fully inhibited by DCPIB. Collectively, these data suggest that this swell-activated adipocyte chloride current is VRAC or VSOR, as identified previously in numerous other cell types 25, 26 , including adipocytes 27 .
SWELL1/LRRC8a is required for swell-activated VRAC in adipocytes
As SWELL1-LRRC8-complexes have been recently shown to form the ion channel responsible for VRAC in several common cell lines 19, 20, 28 , we next asked whether SWELL1 was required for adipocyte VRAC. We generated an adenovirus expressing a short-hairpin RNA directed to SWELL1 mRNA (Ad-shSWELL1-mCherry) to knockdown SWELL1 in both mature, primary adipocytes and in adipocyte cell lines, while a scrambled shRNA served as a control (Ad-shSCR-mCherry). We confirmed robust knockdown (KD) of SWELL1 mRNA ( Supplementary Fig. 1a ) and protein ( Supplementary  Fig. 1b ) in cultured human preadipocytes upon adenoviral shRNA transduction. To knockdown SWELL1 in mature, primary murine adipocytes, we injected Ad-shSWELL1/shSCR-mCherry directly into iWAT of mice and then isolated and recorded from patch-clamped mCherry positive adipocytes five days later ( Fig. 2a ). ShRNAmediated SWELL1 knockdown nearly abolished all swell-activated VRAC in murine adipocytes as compared to the scrambled shRNA control (Fig. 2b,c) , in addition to VRAC in both murine 3T3-F442A adipocytes ( Supplementary Fig. 1c,d ) and in a human adipocyte cell line ( Supplementary Fig. 1e,f) .
As a complementary approach, we used CRISPR-cas9 gene editing 29 to disrupt SWELL1 using either a single guide RNA (gRNA; Supplementary Fig. 2a ) or double gRNA ( Supplementary Fig. 2b ,c) approach in the 3T3-F442A adipocyte cell line. From two independent SWELL1 CRISPR-cas9 knockout (KO) adipocyte cell lines we find that VRAC is entirely abolished (Fig. 2d,e ) upon SWELL1 gene disruption, and this is associated with complete loss of SWELL1 protein (Fig. 2f ).
To achieve conditional ablation of SWELL1, we generated mice with flanking loxP sites around SWELL1 Exon 3 by applying a CRISPR-cas9 knock-in approach 30 ( Supplementary Fig. 2d ). Cultured tail-tip fibroblasts from SWELL1 fl mice transduced with adenoviral-Cre-mCherry (Ad-Cre-mCherry) show excision of SWELL1 Exon 3 ( Supplementary Fig. 2e ). Primary adipocytes isolated and cultured from the stromal vascular fraction (SVF; Supplementary Fig. 2f ) also show specific SWELL1 mRNA ablation when transduced (>90% efficient) with Ad-Cre-mCherry ( Supplementary Fig. 2g ,h), and this is associated with ablation of VRAC ( Supplementary Fig. 2i -k). Next, we measured VRAC in mature murine adipocytes isolated from iWAT of SWELL1 fl mice 5-7 days after direct injection with either Ad-mCherry or Ad-Cre-mCherry ( Fig. 2g ). We find that SWELL1 deletion (Ad-Cre-mCherry) entirely ablates swell-induced VRAC in mature adipocytes ( Fig. 2h-j) . Collectively, these data show that SWELL1/LRRC8a is required for swell-induced VRAC currents in both primary adipocytes and adipocyte cell lines.
SWELL1-mediated VRAC is increased in adipocytes of obese mice and humans
As adipocyte hypertrophy is the relevant physiological stimulus encountered in vivo, we asked whether lipid droplet expansion in the setting of obesity could activate SWELL1-mediated VRAC at the adipocyte plasma membrane. We isolated mature adipocytes from iWAT of lean (normal chow: NC, 10-12 weeks) and obese (high-fat diet, HFD, 10-12 weeks; Supplementary Fig. 3a ) mice and measured VRAC using the perforated-patch configuration of the patch-clamp technique ( Fig. 3a , see Methods) pre-and post-hypotonic swelling. Similar to positive-pressure swelling, we discovered that a minimal amount of adipocyte swelling is required (∼1-2% increase in diameter) to activate robust SWELL1-mediated currents ( Fig. 3a,b ; i to ii)-easily within the physiological range of adipocyte expansion/contraction occurring during feeding/fasting. As expected, adipocytes isolated from obese mice are hypertrophic compared to lean mice based on cell size ( Fig. 3c ) and cell capacitance ( Fig. 3d) ; the latter providing a measure of adipocyte surface area. SWELL1-mediated current densities in hypertrophic adipocytes are significantly increased compared to adipocytes of lean mice, both upon adipocyte swelling ( Fig. 3e -g) and, importantly, prior to swelling ( Fig. 3e ,h, pre-stimulation). To determine whether these increases in SWELL1-mediated currents measured in hypertrophic adipocytes result from SWELL1-LRRC8 channel activation versus augmented SWELL1-LRRC8 channel expression, we performed quantitative polymerase chain reaction (qPCR) to measure relative mRNA expression levels of SWELL1/LRRC8a, LRRC8b, LRRC8c, LRRC8d and LRRC8e in adipocytes from lean compared to obese mice ( Supplementary Fig. 3b ), and found a non-statistically significant trend toward increasing SWELL1 (2.2-fold; P = 0.07) expression, with significant increases in LRRC8b (3-fold, P < 0.05) and LRRC8d (2.9-fold, P < 0.01). Therefore, it is possible that augmented adipocyte VRAC currents in obesity occur due to SWELL1-LRRC8 channel activation by adipocyte hypertrophy, in addition to coordinated increases in SWELL1/LRRC8a, LRRC8b and LRRC8d expression. We next asked whether VRAC is also activated in hypertrophic adipocytes of obese humans and patch-clamped mature adipocytes freshly dissociated from visceral fat harvested from obese, BMI > 30, bariatric surgery patients compared to leaner non-bariatric patients, BMI < 30 (see Supplementary Fig. 3c ). As in mice, there is a significant, although less marked, increase in adipocyte size ( Fig. 3i ) and adipocyte capacitance ( Fig. 3j ) in obese compared to leaner non-bariatric patients. Similarly, VRAC is augmented upon swelling in adipocytes from obese compared to leaner patients ( Fig. 3k-m 
as is basal or 'pre-activated' VRAC inward current ( Fig. 3k ,n, pre-stimulation). Taken together, these data strongly suggest that SWELL1-mediated VRAC is augmented in adipocytes as they hypertrophy in obese mice and humans.
SWELL1 regulates lipid content and glucose metabolism in 3T3-F442A adipocytes
To obtain unbiased insight into putative SWELL1-dependent molecular pathways impacting adipocyte function we performed genomewide RNA sequencing (RNA-Seq) of wild-type (WT) and CRISPR-cas9-mediated SWELL1 KO adipocytes. This revealed significant differences in RNA transcriptional profile with 9090 differentially expressed genes based on a false-discovery rate q-value of 0.25 (Supplementary Fig. 4a and Supplementary Table 1 ). Gene Set Enrichment Analysis (GSEA) of the RNA sequencing data highlights pathways related to hypoxia, adipogenesis, glucose metabolism and insulin Figure 2 SWELL1 mediates a swell-activated current in adipocytes. (a) Experimental approach for SWELL1 knockdown, isolation and recording of primary mature mouse adipocytes from iWAT. (b,c) Representative VRAC current-voltage plot (b) and mean outward (+100 mV) and inward (−100 mV) VRAC current density (c) in Ad-shSCR (black, n = 6) and Ad-shSWELL1 (red, n = 6) transduced mature adipocytes upon swell-activation. (d,e) VRAC over time ± hypotonic swelling in WT (grey trace) and in a CRISPR-cas9 SWELL1 knockout (KO, red trace) 3T3-F442A preadipocyte (d) and mean peak outward (+100 mV) and inward (−100 mV) current (e) in WT (n WT = 12) and two independent CRISPR-cas9 SWELL1 knockout (KO1, KO2) adipocyte cell lines (n KO1 = 7, n KO2 = 5). (f) Representative western blot of SWELL1 and β-actin in WT and CRISPR-cas9 SWELL1 KO 3T3-F442A adipocyte cell line (representative of 20+ blots). Uncropped blots are shown in Supplementary Fig. 9a . (g) Experimental approach for generating SWELL1 knockout primary mature mouse adipocytes from iWAT of SWELL1 fl mice. (h-j) Representative VRAC current over time (h), current-voltage plot (i), and mean peak outward (+100 mV) and inward (−100 mV) current density (j) induced by swelling (blue arrows) in WT and SWELL1 KO primary mature adipocytes (n WT = 5, n KO = 6). Significance between the indicated groups in c,e and j was calculated using a two-tailed Student's t-test. Exact P-values are listed in Supplementary  Table 6 . Error bars represent mean ± s.e.m. * (P < 0.05), * * (P < 0.01), * * * (P < 0.001). See also Supplementary Fig. 1 and 2. Scale bar, 100 µm for (g). Fig. 4b and Supplementary Table 2 ). Consistent with a requirement for SWELL1 in adipogenesis, both SWELL1 KO adipocytes ( Fig. 4a ) and cultured SWELL1 KO primary adipocytes ( Fig. 4b ) develop less intracellular lipid than WT as assessed by AdipoRed fluorescence imaging (under high glucose culture conditions, 25 mM). Switching to low-glucose media (5 mM) abolishes this difference in intracellular lipid content between WT and SWELL1 KO adipocytes ( Supplementary Fig. 4c ). These data suggest that impaired glucose uptake, and consequently diminished de novo lipogenesis, underlies the reduction in lipid content in SWELL1 KO adipocytes relative to WT under high-glucose culture conditions. We next measured basal and insulin-stimulated glucose uptake in WT and SWELL1 KO adipocytes using radioactively labelled 2-deoxy-D-glucose. WT adipocytes exhibit the expected increase in glucose uptake upon insulin stimulation 31 , while this effect is abrogated in SWELL1 KO adipocytes ( Fig. 4c ). Transmission electron microscopy (TEM) images of SWELL1 KO adipocytes reveal a significant reduction in glycogen content compared to WT adipocytes under conditions of chronic insulin stimulation (that is, differentiation media, 860 nM) ( Fig. 4d and Supplementary Fig. 4d ). Taken together, these data suggest that SWELL1 is required for both glucose uptake/metabolism and lipogenesis in adipocytes.
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SWELL1 regulates insulin-PI3K-AKT signalling, GLUT4 translocation, GSK3β and FOXO1
As both glucose uptake and lipogenesis require intact insulinphosphoinositol 3-kinase-AKT (insulin-PI3K-AKT) signalling in adipocytes 22, 32 , we next examined the integrity of this pathway in SWELL1 KO adipocytes. SWELL1 deletion in both SWELL1 KO 3T3-F442A adipocytes ( Fig. 4e ) and SWELL1 KO primary adipocytes ( Fig. 4f ) significantly reduced insulin-stimulated pAKT2 (pSerine474) when compared to their respective WT adipocytes, whereas pAKT1 (pSerine473) levels remained constitutively increased. To determine whether SWELL1 silencing in mature adipocytes in vivo also disrupts (l) Current-voltage relationship at peak activation. (m,n) Mean peak outward (+100 mV) and inward (−100 mV) current density after hypotonic activation (m) and pre-stimulation (n) (BMI < 30: n = 7 cells, BMI > 30: n = 13 cells). Significance between the indicated groups in d,j were calculated using a two-tailed Student's t-test; indicated groups in g,h,m,n were calculated using a two-tailed Mann-Whitney U-test. Exact P-values are listed in Supplementary Table 6 . Error bars represent mean ± s.e.m. * (P < 0.05), * * (P < 0.01), * * * (P < 0.001). Scale bars in a,c,i are 50 µm. See also Supplementary Fig. 3 .
insulin-PI3K-AKT signalling we examined insulin-stimulated pAKT2 and pAKT1 in iWAT of mice seven days after direct iWAT injection with Ad-shSCR-mCherry/Ad-shSWELL1-mCherry. Paralleling the in vitro data, iWAT SWELL1 knockdown significantly dampened insulin-pAKT2 signalling without influencing insulin-mediated phosphorylation of AKT1 ( Fig. 4g ).
As insulin-PI3K-AKT2 stimulates glucose uptake via GLUT4 plasma membrane translocation, we directly measured insulinstimulated GLUT4 translocation, using surface biotinylation, and then blotted for GLUT4 in the plasma membrane (PM) versus cytosol (C). We find that insulin-stimulated GLUT4 PM translocation is reduced in SWELL1 KO adipocytes ( Fig. 4h ). As it is well established that phosphorylation-mediated inhibition of the RabGAP AS160 (pThreonine642) is required for insulin-stimulated GLUT4 vesicle docking and fusion with the PM 33, 34 , and that this phosphorylation event is AKT2-specific and AKT1-independent 32 we next examined insulin-stimulated pAS160/AS160. We find that pAS160/AS160 is reduced in SWELL1 KO adipocytes compared to WT ( Fig. 4i) , consistent with the observed reduction in insulin-PI3K-pAKT2-GLUT4 signalling.
Insulin-PI3K-AKT-mediated phosphorylation of glycogen synthase kinase-3β (pGSK3β) inhibits GSK3β activity and subsequently dis-inhibits glycogen synthase, allowing glucose to be stored as glycogen 35 . We find that insulin-stimulated pGSK3β/GSK3β and pGSK3β/β-actin (pSerine9) are reduced in SWELL1 KO adipocytes ( Fig. 4j ), providing a molecular mechanism for the reduction in glycogen granules observed on TEM ( Fig. 4d ). Thus, SWELL1mediated pAKT2 signalling appears to coordinately regulate both independent experiments for pAS160 and N = 6 for pFOXO1 and pGSK3β. Significance between the indicated groups in a-c,e-j were calculated using a two-tailed Student's t-test. Wilcoxon-test used for statistical significance in d. Exact P-values are listed in Supplementary Table 6 .
Uncropped blots for e-j are shown in Supplementary Fig. 9b -p. Statistics source data for e-j can be found in Supplementary Table 7 . Error bars represent mean ± s.e.m. * (P < 0.05), * * (P < 0.01), * * * (P < 0.001). See also Supplementary Fig. 4 .
glucose import via GLUT4 translocation and glycogen synthesis via GSK3β. We next examined the AKT-substrate FOXO1, a transcription factor that suppresses adipocyte differentiation when nuclear localized, but upon insulin-AKT-mediated phosphorylation pFOXO1 becomes excluded from the nucleus-thereby releasing adipocyte differentiation programs 36 . We find that insulin-AKTmediated pFOXO1/FOXO1 and pFOXO1/β-actin (pThreonine24), are enhanced in SWELL1 KO adipocytes ( Fig. 4j) , in a manner similar to pAKT1. Taken together, these data show that SWELL1 is required for insulin-PI3K-AKT2 activity and downstream signalling in adipocytes and suggest that SWELL1 may connect the volume of the expanding adipocyte with 'tuning' of insulin-PI3K-AKT2 signalling.
SWELL1 regulates insulin-pAKT2 signalling via GRB2-dependent interactions
In lymphocytes, SWELL1 connects with PI3K signalling via a growth factor receptor-bound 2 (GRB2) interaction 21 . GRB2 is linked to insulin-receptor (IR) signalling via a direct interaction with insulinreceptor substrate (IRS) 1/2 (ref. 37) and is thought to modulate insulin signalling. We confirmed that GRB2 co-immunoprecipitates (co-IPs) with IR in both 3T3-F442A adipocytes ( Supplementary Fig. 5a ) and HEK cells ( Supplementary Fig. 5b ); and that GRB2 co-IPs with IRS1 (using an epitope-tagged IRS1 construct: Myc-TEV-HA-IRS1) in HEK cells ( Supplementary Fig. 5c ). Next, we tested for an endogenous GRB2-SWELL1 interaction in adipocytes. We find that GRB2 co-IPs with SWELL1 in WT but not SWELL1 KO adipocytes, and that insulin stimulation reduces this SWELL1-GRB2 interaction ( Fig. 5a ), suggesting a dynamic, insulin-dependent SWELL1-GRB2 interaction (see SWELL1/GRB2 densitometry). GRB2 has also been reported to associate with caveolin-1 (Cav1) 38 . Cav1 is enriched in adipocytes 39 , thought to form insulin-signalling microdomains 40 , is required for normal adipocyte insulin signalling 41 and has been described as a cellular mechanosensor 8, 42 that regulates PI3K-AKT signalling 43 . Moreover, there are reports that Cav1 regulates VRAC (ref. 44) , further suggesting a putative SWELL1-Cav1 molecular interaction. We find that Cav1 co-IPs with GRB2 in adipocytes (Fig. 5a ), and SWELL1 also co-IPs with Cav1 in WT but not in SWELL1 KO adipocytes ( Fig. 5b) . These data suggest that SWELL1 resides in an insulin-signalling macromolecular complex that includes Cav1, GRB2, IRS-1, and IR.
It has been proposed that the SWELL1 leucine-rich repeat domain (LRRD) may provide docking surfaces for protein-protein interactions for signalling to various protein-kinases 45 . To determine if SWELL1 LRRD is required for GRB2 binding, we expressed wildtype SWELL1 (Fig. 5c ), and the SWELL1 mutant, SWELL1 91/+35 (Fig. 5d ), in HEK cells and attempted to pull-down these SWELL1 proteins with endogenous GRB2. SWELL1 91/+35 is a mutation which replaces 91 C-terminal LRRD amino acids with 35 amino acids derived from the neighbouring intronic sequence 46 (Fig. 5d ); this partially disrupts the LRRD, and inactivates SWELL1 activity 20 . When WT SWELL1 and SWELL1 91/+35 are transiently expressed at equal levels in HEK cells (SWELL1/β-actin = 1.38; SWELL1 91/+35 /β-actin = 1.41; Fig. 5e ) we find that SWELL1 91/+35 co-IPs with GRB2 less efficiently (SWELL1 91/+35 /GRB2 = 0.07) than WT SWELL1 (SWELL1/GRB2 = 0.31) ( Fig. 5e ), suggesting that the SWELL1 LRRD is required for GRB2 binding.
We next asked how a SWELL1-GRB2 complex may regulate insulin signalling. It is noteworthy that GRB2 loss of function enhances insulin-PI3K-AKT and MAP kinase signalling in cultured hepatocytes 47 and in C2C12 myoblasts 48 ; and also augments insulin signalling and glucose tolerance in vivo 48 , suggesting that GRB2 is a negative regulator of insulin signalling. We find that insulin stimulation reduces both SWELL1-GRB2 and Cav1-GRB2, but not SWELL1-Cav1 interactions in WT adipocytes (Fig. 5a,b ), suggesting that insulin stimulation induces GRB2 dissociation from the insulin-signalling complex, thereby dis-inhibiting downstream insulin signalling. To examine whether the defect in insulin-pAKT2 signalling observed upon SWELL1 KO is due to unrestrained GRB2-mediated inhibition we generated stable WT/GRB2 KD and SWELL1 KO/GRB2 KD adipocytes using a lentiviral shRNA to GRB2. Similar to prior reports in hepatocytes and myoblasts, we observe enhanced insulin-pAKT2 signalling in WT GRB2deficient adipocytes ( Fig. 5f,g,h) , even under non-insulin-stimulated conditions. Importantly, GRB2 KD in SWELL1 KO adipocytes rescues the impairment in insulin-pAKT2 activation, confirming that suppression of insulin-pAKT2 signalling upon SWELL1 ablation is GRB2-dependent ( Fig. 5f ,i,j). Overall, these data suggest that SWELL1 modulates insulin-PI3K-AKT2 signalling by titrating GRB2inhibition of a Cav1-IRS1-IR signalling complex via a C-terminal LRRD-mediated interaction with GRB2.
SWELL1 knockdown reduces adipocyte size, adiposity and impairs glucose tolerance in obese mice
Based on our findings that SWELL1 is required for insulin-PI3K-AKT2 signalling and that SWELL1 is activated in hypertrophic adipocytes in the context of obesity, we asked whether SWELL1 knockdown can influence adipocyte size, adiposity and glucose tolerance in obese mice. We tested the acute effects of SWELL1 knockdown on adipocyte size, by injecting iWAT of obese mice (HFD, 10-12 weeks) with either Ad-shSCR-mCherry or Ad-shSWELL1-mCherry, and after 12 days, isolating and measuring the transduced adipocyte. We find that SWELL1-depleted adipocytes are 28% smaller than control adipocytes ( Fig. 6a,b) , with a leftward shifted size distribution ( Fig. 6c ). To examine the effects of SWELL1 knockdown in vivo during the development of diet-induced obesity we generated adeno-associated viruses (AAV/Rec2) for sustained viral expression of shSWELL1, as this AAV/Rec2 serotype has a high tropism for adipose tissue and can sustain expression for up to 12 months 49 . After direct iWAT injection with either AAV/Rec2-shSWELL1-mCherry or AAV/Rec2-shSCR-mCherry, both groups of mice were placed on a HFD for 16 weeks prior to analysis. Patch-clamp recordings from hypertrophic AAV/Rec2-shSWELL1-mCherry transduced iWAT adipocytes confirm strong SWELL1 silencing compared to AAV/Rec2-shSCR-mCherry at 16 weeks post injection ( Fig. 6d,e ), and this is associated with reduced adipocyte size ( Fig. 6f,g) , as observed with acute adenoviral SWELL1 knockdown in iWAT of obese mice (Fig. 6a-c) . Interestingly, while AAV/Rec2 iWAT transduction is patchy and restricted to the injection site ( Supplementary Fig. 6a , iWAT), we note widespread viral transduction of much of the visceral epididymal white adipose tissue ( Supplementary Fig. 6a , eWAT). In addition, we observe transduction of liver and skeletal muscle ( Supplementary Fig. 6b ), resulting in a pattern of AAV/Rec2 Supplementary Table 6 . Uncropped blots for a are shown in Supplementary Fig. 9q -s; for b in Supplementary Fig. 9u-w ; for e in Supplementary Fig. 9x -z; for f in Supplementary Fig. 9aa . Statistics source data for g,i can be found in Supplementary Table 7 . Error bars represent mean ± s.e.m. * (P < 0.05), * * (P < 0.01), * * * (P < 0.001). See also Supplementary  Fig. 5 .
transduction, involving several insulin-sensitive tissues. Nuclear magnetic resonance (NMR) measurements reveal a trend toward reduced total %fat ( Supplementary Fig. 6c ), accompanied by a small increase in %lean mass ( Supplementary Fig. 6d ). As visceral adipose was preferentially transduced by AAV/Rec2 we speculated that the reduction in global adiposity measured by NMR might be driven by (k) Glucose tolerance test (AAV-shSCR, n = 5 mice; AAV-shSWELL1 n = 6 mice). (l) Insulin tolerance test (AAV-shSCR, n = 6 mice; AAV-shSWELL1, n = 5 mice). Significance between the indicated groups in b,e,f,i,j were calculated using a two-tailed Student's t-test, and k,l calculated using a 2way ANOVA. Exact P-values are listed in Supplementary Table 6 . Error bars represent mean ± s.e.m. * (P < 0.05), * * (P < 0.01), * * * (P < 0.001). See also Supplementary Fig. 6 . Supplementary Table 6 . Error bars represent mean ± s.e.m. * * * (P < 0.001). See also Supplementary Fig. 7 .
contraction of the visceral depot. To discriminate subcutaneous from visceral adipose tissue non-invasively in vivo, we turned to microCT imaging 50 . This revealed a significant reduction specifically in visceral adiposity, with a marked reduction of the epididymal fat depot ( Fig. 6h-j) , consistent with preferential SWELL1 KD in visceral fat.
MicroCT-derived 3D reconstructions of visceral adipose of representative AAV/Rec2-shSCR/shSWELL1-mCherry are shown in Fig. 6h (right panels, red) and in Supplementary Videos 1 and 2, respectively. We next examined both glucose and insulin tolerance in these mice, and found that SWELL1 knock down in vivo is associated with impaired glucose tolerance ( Fig. 6k ) and insulin resistance (Fig. 6l ).
Adipocyte-restricted SWELL1 deletion induces systemic glucose intolerance and insulin resistance
As a complementary approach to the AAV/Rec2-mediated SWELL1 KD experiments we generated adipose-targeted SWELL1 knockout (Adipo KO) mice by crossing SWELL1 fl mice with Adiponectin-Cre mice to achieve adipose-restricted Cre-mediated SWELL1 recombination using the Cre-loxP system 51 (Fig. 7a ). Adipo KO mice show clear adipose-restricted SWELL1 Exon 3 deletion in subcutaneous (iWAT), visceral (eWAT) and brown (BAT) adipose tissue without evidence of recombination in other tissues (Fig. 7a ). SWELL1-LRRC8 currents are entirely ablated in mature Adipo KO adipocytes compared to WT adipocytes (Fig. 7b,c) . At baseline, Adipo KO mice are indistinguishable from littermate SWELL1 fl controls with respect to total body weight ( Fig. 7d ) and adiposity-as assessed by both NMR (Fig. 7e,f) and iWAT/eWAT weights (Fig. 7g,h) . Moreover, there are no differences in adipocyte size ( Supplementary  Fig. 7a-f ). mRNA expression levels of adipocyte differentiation markers, including Adiponectin, C/EBPα, C/EBPβ, and PPARγ are either unchanged or slightly increased in iWAT of Adipo KO mice compared to WT ( Supplementary Fig. 7g ). Despite normal Adipo KO (n = 1,173) adipocyte cross-sectional areas (i) and size distribution (j) measured from iWAT histological sections (h). Measurements pooled from 3 separate experiments. (k) Cross-sectional area distribution of adipocytes from haematoxylin and eosin stained sections from WT and Adipo KO mice raised on a lean diet or HFD (17 weeks). (l) Glucose tolerance test and (m) insulin tolerance test of WT (n = 8) and Adipo KO (n = 7) mice raised on HFD for 12 weeks. Scale bars in h, 50 µm. Data obtained from two separate cohorts of mice. Significance between the indicated groups in a-j were calculated using a two-tailed Student's t-test, and l,m calculated using a 2-way ANOVA. Exact P-values are listed in Supplementary Table 6 . Error bars represent mean ± s.e.m. * (P < 0.05), * * (P < 0.01), * * * (P < 0.001). See also Supplementary  Fig. 8 . adipocyte development, Adipo KO mice exhibit impaired glucose tolerance ( Fig. 7i ) and insulin sensitivity (Fig. 7j ) compared to WT, as observed with systemic AAV/Rec2-mediated SWELL1 knock down (Fig. 6k,i) . Collectively, these data indicate that adipocyte SWELL1 is required for normal systemic glycaemia and insulin sensitivity, but is dispensable for normal postnatal development and differentiation of adipocytes in vivo under basal conditions.
Adipocyte-restricted SWELL1 ablation limits adiposity and adipocyte size in obese mice
As SWELL1-LRRC8 activity is augmented in the setting of obesity in mice and humans we next asked whether SWELL1 is required for adipocyte hypertrophy under conditions of over-nutrition. Adipo KO mice placed on a HFD (16 weeks) gain less weight (Fig. 8a) , despite no consistent differences in daily food consumption (Fig. 8b) , and this is attributed to a marked reduction in percent adiposity (Fig. 8c ) and total adipose mass (Fig. 8d) ; while percent lean mass is proportionately increased (Fig. 8e) , with total lean mass unchanged (Fig. 8f ). Inguinal and epididymal fat pads are also significantly smaller in Adipo KO mice relative to WT littermate controls (Fig. 8g ).
As the reduction in total adiposity and fat pad size observed in Adipo KO mice may arise from fewer adipocytes, smaller adipocytes, or both, we next measured adipocyte size in WT and Adipo KO mice. Measurements of adipocyte cross-sectional areas from haematoxylin and eosin stained sections of HFD Adipo KO and WT iWAT (Fig. 8h ) reveal a striking reduction in adipocyte size in Adipo KO mice relative to WT (Fig. 8i,j) . Overlaying the adipocyte size distribution of lean/obese, WT and Adipo KO mice shows that SWELL1 deletion has no effect on adipocyte size in lean mice, but induces a clear leftward shift in adipocyte size in the setting of obesity toward a lean phenotype (Fig. 8k ). Adipocyte sizes of freshly dissociated adipocytes isolated from HFD Adipo KO iWAT are also significantly smaller than WT ( Supplementary Fig. 8a,b) , with a leftward shifted size distribution ( Supplementary Fig. 8c ); comparable in relative size reduction to our viral knockdown studies ( Fig. 6b -c & f-g). Moreover, glucose intolerance and insulin resistance associated with obesity is further exacerbated in Adipo KO mice compared to WT littermates controls (Fig. 8l,m) .
To determine whether these differences in adipocyte size in Adipo KO relative to WT mice are related to differences in energy expenditure, we measured heat production, VO 2 , VCO 2 , RER, food consumption, activity level and sleep in both lean ( Supplementary Fig. 7h -n) and obese mice ( Supplementary Fig. 8d-j) by indirect calorimetry. There are no differences in any measured parameter in lean WT compared to Adipo KO mice. In obese mice we observe an increase in energy expenditure in Adipo KO mice ( Supplementary Fig. 8d ), but this is associated with an increase in activity level ( Supplementary  Fig. 8h ), which may be driving the increased energy expenditure.
Collectively, these data identify SWELL1 as a swell-activated, volume-sensitive regulator of adipocyte growth, adiposity and insulin signalling and delineates a SWELL1/LRRD-GRB2-Cav1-IRS1-PI3K-AKT2 signalling pathway in adipocytes.
DISCUSSION
Our data show that the recently identified membrane protein, SWELL1 19, 20 , is a critical component of a prominent volume-sensitive ion channel in adipocytes that is activated in the context of adipocyte hypertrophy in obesity, and is required for adipocyte expansion and insulin-PI3K-AKT2 signalling via a LRRD-mediated GRB2 interaction. These findings link SWELL1 with adipocyte insulin signalling and provide a putative molecular mechanism for the previously described effects of adipocyte membrane tension on lipogenesis and intracellular signalling 1-4,7,9 . We propose a working model in which SWELL1 is activated by increases in adipocyte volume during adipocyte hypertrophy, and potentiates insulin-PI3K-AKT2 signalling via C-terminal LRRD interactions with GRB2-Cav1-IRS1-IR to support insulin-mediated GLUT4 PM translocation, glucose import and lipogenesis. In this model, SWELL1 senses adipocyte volumetric expansion and acts as a feed-forward amplifier to further promote adipocyte expansion, energy storage, and enhance insulin-AKT2 signalling during times of caloric excess (feeding). In support of this model, Eduardsen et al. 9 demonstrated that osmotically induced increases in cellular volume could potentiate insulin signalling in 3T3-L1 preadipocytes, through unknown mechanisms. Moreover, Chen and Chalfie 52 recently demonstrated a similar phenomenon in the touch receptor neurons of Caenorhabditis elegans, implying that the concept of 'mechano-tuning' of insulin signalling may be a universal theme in cell biology.
To add further complexity, SWELL1 is known to form heteromultimers with LRRC8b-e 19, 28 , which modifies channel gating, and may influence the diversity of molecular interactions with different protein partners based on the relative abundance of LRRC8b-e in a given cell type or tissue. Therefore, depending on the expression profile of LRRC8 proteins in different tissues, SWELL1 modulation of intracellular signalling may vary in a cell-type dependent fashion. For example, previous studies identified the broadly expressed membrane protein LRRC8c, also named Factor of Adipocyte Differentiation (FAD) 158, as a factor required for adipocyte differentiation 53 and dietinduced obesity 54 -through un-identified molecular mechanisms. As LRRC8c (FAD158) forms a complex with SWELL1 28 and modifies SWELL1-LRRC8 channel function 19, 28 , our findings may provide a mechanism for FAD158/LRRC8c action in adipocyte biology.
It is intriguing that adipose-targeted SWELL1 ablation appears not to grossly affect adipocyte development, adipocyte size or adiposity under basal conditions, but results in significant suppression of adipocyte expansion in the setting of obesity. This is in line with our observation that SWELL1 is activated in hypertrophic adipocytes from obese mice and humans, suggesting that SWELL1 activity is primarily required for extremes of adipocyte expansion in obese states. This phenotype is also consistent with the finding that SWELL1 deletion disrupts specifically PI3K-AKT2 signalling-an AKT isoform that is dispensable for adipocyte development 22, 55 , and instead is primarily important in 'obesogenic' adipogenesis 56 and systemic glucose homeostasis 22, 55 , in contrast to AKT1 23, 57 . Moreover, Adipo KO mice phenocopy AKT2 −/− mice 22, 55 and adipose-targeted GLUT4 KO mice 58 with respect to systemic glucose intolerance and insulin resistance, supporting the notion of a SWELL1-regulated insulin-AKT2-GLUT4 pathway.
In summary, we show that SWELL1 is a required component of a volume-sensitive ion channel complex that is activated in the setting of obesity and positively regulates adipocyte lipid content and glucose uptake via GRB2-mediated modulation of insulin-PI3K-AKT2 signalling. As SWELL1 is broadly expressed, and PI3K-AKT pathway ubiquitous, and fundamentally intertwined with numerous signalling pathways we anticipate that SWELL1 signalling will be physiologically and pathophysiologically important in a multitude of different tissues and disease states.
METHODS
Methods, including statements of data availability and any associated accession codes and references, are available in the online version of this paper.
Note: Supplementary Information is available in the online version of the paper DOI: 10.1038/ncb3514 METHODS Patients. The University of Iowa Institutional Review Board (IRB) approved the study involving human samples. Informed consent was obtained from human subjects. Visceral adipose tissues were obtained from esophageal fat pads, either from morbidly obese patients who underwent bariatric surgeries or normal control subjects who underwent non-bariatric surgeries at the University of Iowa Hospital. Patients were anonymous to the research team except for information of gender, age, and BMI. Fat tissue was kept in ice cold PBS and transferred to laboratory within 20 min.
Animals. The Institutional Animal Care and Use Committee of the University of Iowa approved all experimental procedures involving animals. Only male mice were used in all studies. The experiments were not randomized. The investigators were blinded to allocation during experiments and outcome assessment for certain experiments: microCT imaging and quantification of adiposity; nuclear magnetic resonance imaging; glucose tolerance testing; and insulin tolerance testing. All C57BL/6 mice involved in the study were purchased from Charles River Labs. Adiponectin-Cre mice were a kind gift from M. Potthoff at The University of Iowa. All the mice were housed in a temperature-, humidity-, and light-controlled room and allowed free access to water and food. High-fat diet was used to induce obesity in mice. Mice were fed ad libitum with 60% kcal% high-fat Diet (Research Diets) for 12-16 weeks starting at the age of 4 ∼ 6 weeks. The weights were recorded weekly after initiation of HFD. Daily food consumption was calculated weekly by monitoring the total food consumption for WT and Adipo KO mice, measured as mean food consumption for one to four mice caged together.
Adenoviruses and Adeno-associated viruses preparation. Human adenovirus type 5 with hLRRC8A-shRNA and scrambled non-targeting control was obtained from Vector Biolabs (Ad5-mCherry-U6-hLRRC8A-shRNA, 2.2 × 10 10 PFU ml −1 , Ad5-U6-scramble-mCherry, 1 × 10 10 PFU ml −1 ). Human adenovirus type 5 with Ad5-CMV-Cre-mCherry (3 × 10 10 PFU ml −1 ) and Ad5-CMV-mCherry (1 × 10 10 PFU ml −1 ) were obtained from The University of Iowa Viral Vector Core. The AAV serotype rec2 with hLRRC8A-shRNA and mCherry reporter (AAVrec2-mCherry-U6-hLRRC8a, 2.2 × 10 13 vector genomes (vg) ml −1 ) were produced by Dr. Lei Cao's Laboratory as previously described 49 . Scrambled non-targeting shRNA was used as a control (AAVrec2-mCherry-Scramble, 3.8 × 10 13 vg ml −1 ).
Primary mature adipocytes isolation. Mouse inguinal fat pads were removed and washed with HBSS (Gibco) and then minced. The minced tissue was digested for 30-40 min at 37 • C in 10 ml of digestion buffer (3% BSA in HBSS, 1 mM CaCl 2 , 1 mM MgCl 2 , 8 mg ml −1 collagenase D, 2.4 units ml −1 Dispase II). The digested tissue was filtered through a 220 µm mesh, and centrifuged at 1,000 r.p.m. for 3 min. The supernatant, which contained mature adipocytes, was collected. Cells were washed with DMEM/F12 medium (Sigma) containing 10%FBS (Gibco), 100 IU penicillin and 100 µg ml −1 streptomycin by repetitive pelleting. For mature adipocytes, the final adipocyte suspension was aliquoted in a 24-well plate. Glass coverslips coated with Matrigel (Corning) were placed on the surface of the cell suspension upside down, and incubated at 37 • C for at least 20 min. The coverslips with adipocytes attached were then placed on the bottom of a perfusion chamber for subsequent experiments. Human fat samples were processed using the same protocol.
Mouse primary stromal vascular fraction (SVF) isolation for culture. SWELL1 fl mouse inguinal fat pads were prepared and digested as described above. To isolate SVF, the pellet was saved and washed with DMEM/F12 medium (Sigma) containing 10%FBS (Gibco), 100 IU penicillin and 100 µg ml −1 streptomycin by repetitive pelleting. SVFs were seeded on collagen-coated plates (BD Bioscience) for subsequent culture and differentiation (see Cell culture, below).
Cell culture.
No cell lines used in this study were found in the database of commonly misidentified cell lines that is maintained by ICLAC and NCBI Biosample. The cell lines were not authenticated. HEK and 3T3-F442A (Sigma-Aldrich) cells were grown in Dulbecco's Modified Eagle Medium (DMEM) containing 4.5 g l −1 glucose, 10% FBS (Gibco) and 100 IU penicillin and 100 µg ml −1 streptomycin. Both cell lines tested negative for mycoplasma. To induce 3T3-F442A cells differentiation, confluent cells were cultured in the above medium supplemented with 5 µg ml −1 (860 nM) insulin (Cell Applications). To compare lipid content under low glucose condition, DMEM containing 1 g l −1 glucose was used. Primary mouse SVFs were seeded in collagen-coated plates (BD Bioscience) and cultured in a growth medium which consisted of DMEM/F12 medium (Sigma) supplemented with 10% FBS, 100 IU penicillin and 100 µg ml −1 streptomycin. When cells reached confluence, adipocytes differentiation was induced by changing the above medium to a differentiation medium. The differentiation medium was the growth medium supplemented with 0.5 M IBMX (Cayman), 1 µM Dexamethasone (Cayman), 5 µg ml −1 (860 nM) Insulin and 1 µM Rosiglitazone (Enzo). Cells were maintained in the differentiation medium for 10-12 days. For immortalized human preadipocytes (NPAD) 24 , the cells were cultured in Preadipocyte Basal Medium 2 (PBM-2) (Lonza) supplemented with 10% FBS, L-glutamine, gentamicin, and amphotericin according to the manufacturer's instructions. For differentiation, the culture medium was supplemented with dexamethasone, IBMX, indomethacin, and human insulin prepared according to the manufacturer's instructions (Lonza). Cells were left in the differentiation medium for 10-12 days.
Adenovirus and adeno-associated virus injections to mouse inguinal adipose depot. Mice were anaesthetized by isoflurane (1-4%), and placed in a prone position. The skin above the inguinal fat pad was prepared in a sterile fashion and an incision made to expose the inguinal fat pad. Virus diluted in sterile PBS: 1 × 10 10 vg/20 µl (adeno-associated virus) or 1 × 10 9 PFU/40 µl (adenovirus) for lean mouse, 2 × 10 9 PFU/100 µl (adenovirus) for obese mouse was injected at multiple sites of the fat pad using a 0.3 cm 3 , 31G insulin syringe. After the injection, incisions were closed with surgical clips.
CRISPR-cas9-mediated gene knockout in 3T3-F442A cells.
Guide RNA sequences targeting SWELL1 gene were designed using a web-based CRISPR design tool (http://crispr.mit.edu) ( Supplementary Table 4 ) and were cloned in a Cas9 expressing bicistronic vector (pSpCas9(BB)-2A-Puro) as described 59 . 3T3-F442A cells were either nucleofected with single (399 for KO1) or double (295/399 for KO2) guide vectors using the Amaxa Cell Line Nucleofector Kit V per manufacturer's instructions. Puromycin selection medium (1 µg ml −1 ) was added 48 h after nucleofection and maintained for five days. The cell pool was expanded and clonally diluted. Genomic modifications of individual clones were confirmed by Sanger sequencing for KO1, whereas a PCR screen was used to confirm the deletion of the gene fragment between the two guide pairs for KO2. Control 3T3-F442A adipocytes were either WT 3T3-F442A adipocytes or 3T3-F442A clonal lines isolated from the cas9/gRNA transfections that did not undergo CRISPR-cas9-mediated gene editing.
Generation of WT/GRB2KD and SWELL1 KO/GRB2 KD 3T3-F442A adipocytes.
Lenti GRB2 and LUC (luciferase) shRNAs, packaging, and envelope plasmids are kind gifts from J. C. Houtman at The University of Iowa. The LUC shRNA was used as a control. Viral production and transduction were performed as described in Bilal and colleagues 60 . In brief, lentiviral vector plasmid, packaging, and envelope plasmids were transfected into 293T cells. Virus containing supernatant was harvested and used to transduce WT and SWELL1 KO 3T3-F442A cells. Cells were incubated with virus in the presence of 8 µg ml −1 hexadimethrine bromide (Sigma) for 72 h. Post transduction, the cells were selected with 0.5 µg ml −1 puromycin. Puromycin was then gradually increased to 2 µg ml −1 (0.5 µg ml −1 increments). Non-transduced cells were used as selection control. Selection was maintained for an additional week after the selection control cells were 100% sloughed off. The transduced cells were then cultured and differentiated as described in Cell culture.
Generation of CRISPR-cas9-mediated SWELL1 floxed (SWELL1 fl ) mice and Adipose-targeted SWELL1 KO mice (Adipo KO mice). SWELL1 intronic sequences were obtained from Ensembl Transcript ID ENSMUST00000139454. All CRISPR-Cas9 sites were identified using ZiFit Targeter Version 4.2 (http://zifit.partners.org/ZiFiT). Sites with the presence of G and A nucleotides at sgRNA position 1-4 and GC content between 35 and 75% were preferred. Sites with potential off-target binding were identified with the CRISPR design tool (http://crispr.mit.edu). A full list of potential off targets for each CRISPR-Cas9 target sequence was obtained using CasOT (http://eendb.zfgenetics.org/casot). Pairs of oligonucleotides corresponding to the chosen CRISPR-Cas9 target sites were designed, synthesized, annealed, and cloned into the pX330-U6-Chimeric_BB-CBh-hSpCas9 construct (Addgene plasmid # 42230), following the protocol detailed in Le Cong and colleagues 61 . Oligonucleotides are listed in Supplementary Table 5 . ssODNs ( Supplementary Table 5 ) donors were designed to incorporate a LoxP sequence and unique restriction enzyme site at the cut site of the CRISPR-Cas9 target sequence along with 60 bp of homology on either side. CRISPR-Cas9 reagents and ssODNs were injected into the pronuclei of F1 mouse strain embryos at an injection solution concentration of 5 ng µl −1 and 75-100 ng µl −1 , respectively. Correctly targeted mice were screened by PCR across the predicted loxP insertion sites on either side of Exon 3. In mice that showed the expected shift in amplicon size from ssODN insertion, we subsequently performed restriction enzyme digest on the PCR product to further confirm correct ssODN insertion. Adipo KO mice were then generated by crossing SWELL fl/fl mice with Adiponectin-Cre mice to obtain Adiponectin-Cre/SWELL1 fl/fl (Adipo KO) mice. These mice were maintained on a C57B6/129 mixed background. Age-and gender-matched SWELL1 fl/fl littermates served as controls.
Induction of SWELL1 knockout in adipocytes isolated from SWELL1 fl mice. SVFs were isolated from SWELL1 fl mice as described above, and cultured in DMEM/F12 medium with 10% FBS. Once cells reach 30-40% confluency, culture medium was switched to DMEM/F12 with 2% FBS. Adenovirus was added to the medium (MOI 100) and incubated with cells for 6 h. The cells were then washed with fresh medium three times and cultured in DMEM/F12 medium with 10% FBS for another 5-7 days before differentiation.
RNA isolation and quantitative RT-PCR. Total RNA was isolated from either adipocytes or inguinal fat pads of WT/Adipo KO mice solubilized in TRIzol using PureLink RNA kit (Life Technologies). Complementary DNA (cDNA) was synthesized using iScript Reverse Transcriptase kit (Bio-Rad) with 1 µg of purified RNA. qRT-PCR reaction was set up using Power SYBR green PCR master mix (Applied Biosystems) containing 0.5 µl of cDNA and the amplification curves were monitored in a StepOnePlus Real-Time PCR instrument (Applied Biosystems). All measurements were carried out in triplicate and GAPDH was used as internal standard for C T calculations. The qRT-PCR primers used are listed in Supplementary Table 3 .
RNA Sequencing and analysis. The libraries were prepared using the Illumina TruSeq stranded mRNA Sample Preparation kit (Illumina) using 500 ng of input total RNA. The molar concentrations of the indexed libraries were measured using the High Sensitivity DNA kit (Agilent Technologies) and combined equally into one pool. The molar concentration of the pool was measured using the Illumina Library Quantification Kit (KAPA Biosystems) and sequenced on the HiSeq 2500 sequencer (Illumina) with a 100 bp Paired-End SBS chemistry (Illumina).
Paired-end FASTQ files were aligned to the Mus_musculus_GRCm38_Ensembl reference genome with TopHat v8.7on GenePattern. Aligned BAMs were used as input to Cufflinks v2.02 for transcript quantification. FPKM files from Cufflinks were converted to GCT files via the GenePattern module Fpkm_trackingToGct. Differential expression analyses were computed by t-test in R. Corrections for multiple hypotheses were performed with the Benjamini Hochberg method. Gene Set Enrichment was performed from the pre-ranked differentially expressed genes (ranked by t-score) using the GSEA Preranked GenePattern module with C2-Biocarta as the gene sets database.
Electrophysiology. All experiments were conducted at room temperature. Currents were recorded with either an Axopatch 200B amplifier or a MultiClamp 700B amplifier paired to a Digidata 1550 digitizer, and both used pClamp 10.4 software. For mechanical swelling, whole-cell recordings were performed in extracellular solution (in mM): 135 NaCl, 5.4 CsCl, 10 HEPES, 10 Glucose, 1 CaCl 2 , 3 MgCl 2 , 0.1 CdCl 2 , pH 7.4 with NaOH, and positive pressure applied via patch pipette. In a subset of experiments, a pressure manometer was placed in-line with the patch pipette to quantify the positive pressure applied to achieve mechanical swelling. The intracellular solution contained (in mM): 120 L-aspartic acid, 20 CsCl, 1 MgCl 2 , 5 EGTA, 10 HEPES, 5 MgATP, 120 CsOH, 0.1 GTP, pH 7.2 with CsOH. For hypotonic swelling, extracellular solution consisted of the following (in mM): 90 NaCl, 2 CsCl, 1 MgCl 2 , 1 CaCl 2 , 10 HEPES, 10 mannitol, pH 7.4 with NaOH (210 mOsm kg −1 ). The isotonic extracellular solution consisted of the same composition above, but with 110 mM instead of 10 mM mannitol (300 mOsm kg −1 ). Swell-activated current was elicited by perfusing cells with hypotonic solution (210 mOsm kg −1 ). The patch electrodes were prepared from borosilicate glass capillaries (WPI) and had a resistance of 2.5-4.8 M when filled with pipette solution. For perforated-patch recordings, the intracellular solution was as above, but without ATP and GTP, and contained 360 µg ml −1 Amphotericin B (Sigma). This approach minimally perturbs the adipocyte plasma membrane, protects against lipid occluding the patch pipette during recordings, and permits controlled activation of SWELL1-mediated current (via hypotonic swelling) which allows for more accurate quantification than can be achieved using positive-pressure-induced adipocyte swelling in a whole-cell configuration. The holding potential was 0 mV. Voltage steps were elicited from a 0 mV holding potential from −80 to +80 mV in 20 mV increments every 1 s. Voltage ramps from −100 to +100 mV (at 0.4 mV ms −1 ) were applied every 4 s. Sampling interval was 100 µs and filtered at 10 KHz. For perforated-patch recordings, cells with a membrane resistance below G or access resistance above 20 M were discarded.
Immunoblotting and immunoprecipitation. For iWAT western blot, the inguinal fat pads were harvested 10 min after the mouse received an intraperitoneal insulin (5 unit kg −1 BW) injection. Fat tissues were minced and homogenized in cold RIPA buffer (150 mM NaCl, 20 mM HEPES, 1% NP-40, 5 mM EDTA, PH 7.4) with added proteinase/phosphatase inhibitors (Roche).
For cultured 3T3-F442A and primary adipocytes, cells were washed twice with ice cold PBS, and lysed with the same lysis buffer as above for 30 min on ice. Lysates were then further lysed with two rounds of 10-20 s sonication, and centrifuged at 14,000×g for 15 min at 4 • C. Supernatant was collected, and protein concentration determined using a DC protein assay kit (Bio-Rad). For immunoblotting, equal amounts of protein (20-50 µg) were boiled with SDS loading buffer, electrophoretically separated in 4-15% gradient SDS-PAGE gel (Bio-Rad) under reducing conditions and transferred to PVDF membranes (Bio-Rad). For immunoprecipitation experiments, 1 mg of protein lysate was incubated with the specific antibody at 4 • C for 4 to 8 h. 30 µl of equilibrated protein A/G sepharose beads (GE) were added, followed by an additional 2-4 h of incubation at 4 • C. The beads were then washed three times with RIPA buffer, re-suspended in laemmli buffer (Bio-Rad), boiled for 5 min, separated by SDS-PAGE gel and then transferred to PVDF membranes. Membranes were blocked with 5% BSA in TBST buffer (0.2 M Tris, 1.37 M NaCl, 0.2% Tween20, pH 7.4) at room temperature for one hour, then incubated with primary antibody either at room temperature for 2 h or 4 • C overnight. Membranes were then incubated with corresponding secondary antibody (Bio-Rad, Goat-anti-rabbit #170-6515, Goat-anti-Mouse #170-5047; abcam, Mouse-anti-Rabbit IgG heavy chain #ab99702 or mouse-anti-Rabbit IgG light chain #ab99697, all used at 1:10,000) at room temperature for one hour. The signals were visualized by chemiluminescence (Pierce) and imaged using a ChemiDoc XRS+ imaging system (Bio-rad). Protein band intensities were analysed using ImageJ software (National Institute of Health). To measure insulin-stimulated GLUT4 translocation, differentiated 3T3-F442A adipocytes were serum starved for 6 h, and insulin (0 and 100 nM) stimulated for 15 min. Cells were placed on ice for 10 min to stop trafficking. The cell surface was labelled for 30 min on ice with 0.5 mg ml −1 EZ-link Sulfo-NHS-Biotin (Thermo-Pierce) in PBS. After quenching with 100 mM glycine in PBS, the cells were lysed in the same lysis buffer described above. 1 mg of each protein lysate was diluted to 1 µg µl −1 and incubated with 50 µl of NeutrAvidin beads (Thermo-Pierce) for 16 h at 4 • C prior. The beads were washed three times with RIPA buffer, re-suspended in 2 X laemmli buffer (Bio-Rad), boiled for 10 min, separated by SDS-PAGE gel and western blot performed as described above. Caveolin-1 (Cav1) served as an internal control to confirm equal PM protein loading between insulin-stimulation conditions.
The primary antibodies used in the current study include: from Cell Signaling: anti-phospho Akt1 (#9018), anti-phospho Akt2 (#8599), anti-Akt (#4685), anti-IR (#3020), anti-Cav1 (#3267), anti-phospho-AS160 (#4288), anti GSK-β (#9832), antiphospho-GSK-β (#9336), anti-phospho-FoxO1(Thr24)/FoxO3a(Thr32) (#9464), anti-FoxO1 (#9462) and anti-β-Actin (#8457); from Santa Cruz: Anti-Grb2 (sc-255); from Covance: Anti-HA (MMS-101P); from Millipore: Anti-Glut4 (#07-1404), and anti-AS160 (#07-741); and from BD Scientific: Anti-Grb2 (#610111). Anti-LRRC8a was a kind gift from T. J. Jentsch 19 . All primary antibodies were used at 1:1,000, except for Anti-Grb2 (BD) at 1:5,000, Anti-LRRC8A at 1:3,000.
AdipoRed imaging. Lipid content was quantified using AdipoRed assay reagent (Lonza). In brief, differentiated cells were washed with PBS (pH 7.4) three times, and incubated with AdipoRed solution at room temperature for 10 min. Cells were again washed gently with PBS. Fluorescence signal was measured with an excitation wavelength of 485 nm and an emission wavelength of 572 nm. Images were captured using an ORCA-Flash4.0 HAMAMATSU digital camera C11440 (HAMAMATSU, Japan). Fluorescence intensity quantifications were carried out using Metamorph software (Molecular Devices).
Isolated adipocyte size measurement. For mature adipocyte size measurement, coverslips with adipocytes attached were transferred to a bath chamber on the stage of an inverted microscope (IX73, Olympus) and visualized using a 20× or 40× objective lens (Olympus). Cell images were captured using an ORCA-Flash4.0 HAMAMATSU digital camera C11440 (HAMAMATSU, Japan) and recorded using Metamorph software (Molecular Devices). The cross-sectional area was measured as an indicator of the cell size, using Metamorph software.
Glucose uptake. 3T3-F442A cells incubated in 24-well culture dishes were washed three times with serum-free DMEM, then serum starved for 16-18 h in 5 mM Glucose DMEM and 1% BSA. Cells were then washed two times with PBS and incubated in glucose-free and pyruvate-rich (1 mM) DMEM (Sigma D5030-10X1L) for 30 min at 37 • C with 5% CO 2 . Cells were then treated with or without cytochalasin B (30 µM final, in DMSO Sigma C6762-10 mg). H 3 2-deoxy-D-glucose (2-DOG) (NET 328A001 ml, Perkin Elmer) was diluted 1:40 in H 1 2-DOG (Sigma D6134-5g) then added to cells at a final concentration of 10 mM 2-DOG. Insulin was then added at a final concentration of 100 nM and cells were incubated for 30 min at 37 • C with 5% CO 2 . Following incubations cells were washed three times with PBS, and suspended in 500 µl 1 M NaOH by pipetting up and down. Cell lysates were then freeze thawed, twice diluted in Ultima Gold scintillation fluid, and analysed using a Beckman Coulter LS-6500 scintillation counter. Protein concentrations were assessed in parallel using BCA analysis. H 3 Content was then normalized to H 3 2-DOG standard curves and glucose uptake values were generated normalized to protein content.
Electron microscopy and glycogen estimation. WT and SWELL1 KO 3T3-F442A adipocytes were fixed using 2.5% glutaraldehyde in 0.1 M sodium cacodylate for DOI: 10.1038/ncb3514 30 min at room temperature (RT). After a rinse with 0.1 M sodium cacodylate, the adipocytes were fixed in a buffer containing 1% osmium tetroxide and 1.5% potassium ferrocyanide for 30 min at RT. Cells were stained with 2.5% uranyl acetate followed by gradient dehydration with 25 to 100% ethanol, infiltrated with Eponate 812 before overnight polymerization at 70 • C. Ultrathin sections (80 nm) were cut using a Leica UC6 ultramicrotome and placed on Formvar and carboncoated copper grids. After staining with 2.5% uranyl acetate and Reynold's lead citrate for 2 min each, respectively, the grids were viewed under a JEOL JEM-1230 transmission electron microscope. ImageJ software was used to calculate the mean glycogen particle size from a total of 1,352 particles in five different fields of cell surfaces visualized in two individual grids.
Metabolic phenotyping. The investigators were blinded to allocation during experiments and outcome assessment for all metabolic phenotyping. For glucose tolerance tests (GTT), mice were fasted for 6 h. Glucose levels in tail blood were measured with a standard glucometer at the indicated times after an intraperitoneal (IP) injection of D-glucose (1 g kg −1 BW for lean mice and AAV virus injected obese mice; 0.75 g kg −1 BW for HFD mice). For insulin tolerance test (ITT), mice were fasted for 4 h and blood glucose levels were measured at the above indicated times after an IP injection of insulin (HumulinR, 1 U kg −1 BW for lean mice and AAV virus injected obese mice; 1.25 U kg −1 BW for HFD mice). Mouse body composition (fat and lean mass, and water content) was measured by nuclear magnetic resonance (NMR) 18 . Visceral and subcutaneous fat were imaged by a Siemens Inveon PET/CT/SPECT small animal scanner 62 . CT parameters were 220 • degree of rotation, 360 steps, 500 ms exposure time, 50 kV/500 µA, binning of 4. Analysis was performed on Inveon Research Workplace 4.2.0.15. Metabolic measurements of energy expenditure, respiratory exchange ratio, oxygen consumption, carbon dioxide production, food intake, and physical activity were performed using CLAMS (Comprehensive Lab Animal Monitoring System, Columbus Instruments) by University of Iowa Metabolic Phenotyping Core.
Histological analysis. Tissues were fixed in 1X zinc-formalin for 24-48 h at 4 • C. Paraffin embedding, sectioning, and haematoxylin and eosin staining were performed by University of Iowa Central Microscopy Facility. Images were taken on an Olympus BX-61 light microscope (Olympus) at 20X. Adipocyte area was measured using ImageJ or Metamorph software.
Statistics and reproducibility.
Statistical tests used are indicated in the figure legends. All statistical tests were performed using GraphPad Prism version 6.02 for Windows (GraphPad Software). No samples or animals were excluded from the analysis. No statistical method was used to predetermine sample size. Neither samples nor animals were randomized. Student's t-test was used for single comparisons, based on the data approximately matching a normal distribution. Wilcoxon or Mann-Whitney test was used as non-parametric test, for data that was not normally distributed. 2-Way analysis of variance (ANOVA) was used for GTT and ITT analysis. Data are expressed as mean ± s.e.m., and P < 0.05 was considered statistically significant. Unless specified, * P < 0.05, * * P < 0.01, * * * P < 0.001, and not significant (NS) P > 0.05.
Data availability.
Deep-sequencing (RNA-seq) data that support the findings of this study have been deposited in the Gene Expression Omnibus (GEO) under accession codes GSE86318.
Source data for Figs 4e-j and 5g,h have been provided as Supplementary  Table 7 . All other data supporting the findings of this study are available from the corresponding author on reasonable request. Supplementary Fig. 9ad , and e in Supplementary Fig. 9ae . Representative gel image from 2 independent experiments (c, e). (f) Experimental approach for generating WT and SWELL1 KO primary SVF used for differentiation into cultured primary adipocytes. (i-k) Representative VRAC current over time +/-hypotonic swelling (i), VRAC current-voltage plots upon swelling (j), and mean peak outward (+100 mV) and inward (-100 mV) VRAC current density (k) in WT and SWELL1 primary SVF (n=5-6 each). Significance between the indicated groups in h and k were calculated using a two-tailed Student's t -test. Exact P-values are listed in Supplementary Table 6 . Error bars represent mean ± s.e.m. * (P < 0.05), ** (P < 0.01). 
